TPT1 and neoplasm: Regarding its anticancer activity, it remains unclear whether definitive molecular targets are involved, but it is suggested that translationally controlled tumor protein (TCTP) may be a target, as tumor cells with high TCTP expression are sensitive to artesunate, while those with low TCTP expression show resistance (Efferth, 2005).